MAZZOCCO, Marta
 Distribuzione geografica
Continente #
NA - Nord America 609
EU - Europa 523
AS - Asia 191
AF - Africa 4
Totale 1.327
Nazione #
US - Stati Uniti d'America 606
GB - Regno Unito 201
CN - Cina 141
IT - Italia 75
DE - Germania 55
SE - Svezia 47
IE - Irlanda 39
FI - Finlandia 31
FR - Francia 24
RU - Federazione Russa 18
SG - Singapore 16
BE - Belgio 12
VN - Vietnam 11
UA - Ucraina 8
JP - Giappone 7
NL - Olanda 7
KR - Corea 6
TR - Turchia 5
CA - Canada 2
EG - Egitto 2
ES - Italia 2
BD - Bangladesh 1
BG - Bulgaria 1
IN - India 1
IR - Iran 1
KG - Kirghizistan 1
MA - Marocco 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.327
Città #
Southend 174
Ann Arbor 91
Chandler 88
Jacksonville 82
Woodbridge 53
Ashburn 45
Dublin 39
Verona 38
Houston 37
Beijing 35
New York 23
Wilmington 17
Shenyang 14
Jinan 13
Brussels 12
Helsinki 11
Lawrence 11
Los Angeles 11
Nanjing 11
Princeton 11
Singapore 11
Hebei 9
Haikou 8
Dong Ket 7
Amsterdam 6
Auburn Hills 6
Cambridge 6
Seoul 6
Boardman 5
Düsseldorf 5
Falls Church 5
Hangzhou 5
Nanchang 5
Nürnberg 5
Zhengzhou 5
Cagliari 4
Kyoto 4
Seattle 4
Tianjin 4
Changsha 3
Fairfield 3
Guangzhou 3
Jiaxing 3
Kent 3
Norwalk 3
Redwood City 3
Taizhou 3
Dallas 2
Detroit 2
Dongguan 2
Fuzhou 2
Milan 2
Mit Ghamr 2
Ningbo 2
Ottawa 2
Padova 2
Paris 2
San Mateo 2
Sindelfingen 2
Taiyuan 2
Andover 1
Bhavnagar 1
Bishkek 1
Bucharest 1
Chaoyang 1
Chicago 1
Dearborn 1
Dhaka 1
Felgueiras 1
Guishan 1
Hongtong 1
Lanzhou 1
Legnaro 1
Ljubljana 1
Madrid 1
Monmouth Junction 1
Montgomery 1
Nottingham 1
Pittsburgh 1
Redmond 1
Sabz 1
San Jose 1
Sofia 1
Tokyo 1
Washington 1
Totale 1.001
Nome #
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 174
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 165
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 164
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 163
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 121
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 109
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 101
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 100
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 96
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 88
CONTROL OF CANCER IMMUNOEDITING BY AUTOLOGOUS CELLULAR VACCINE AND EFFICACY ASSESSMENT OF IFN-alpha-ENGINEERED MESENCHYMAL STROMAL CELLS (MSCs) IN A MOUSE PLASMACYTOMA MODEL 83
Totale 1.364
Categoria #
all - tutte 3.633
article - articoli 1.291
book - libri 0
conference - conferenze 2.069
curatela - curatele 0
other - altro 273
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020168 0 0 7 15 15 18 10 20 6 19 32 26
2020/2021174 8 17 19 14 20 19 5 13 13 3 26 17
2021/2022130 14 36 2 9 14 10 3 7 7 4 8 16
2022/2023237 13 35 17 36 23 59 1 17 26 0 6 4
2023/2024156 3 3 17 26 11 32 6 13 2 16 19 8
2024/202545 13 18 14 0 0 0 0 0 0 0 0 0
Totale 1.364